Vai al contenuto principale

Ricerche

Analisi finanziarie e report  a supporto della clientela istituzionale e corporate nelle decisioni di investimento.

2024 M03 04

Business update: focus on protection, synergies and capital

2024 M03 04

Undemanding valuation for a high-growth company

2024 M02 29

Preliminary FY 23 results and 2024-26 business plan

2024 M02 23

FY 23 results in line with expectations and target double digit growth of revenue and EBITDA in 2024

2024 M02 15

FY 23 results met guidance and FY 24 guidance in line with previous outlook

2024 M01 11

Post-integration of Luminex, Diasorin plots new growth pathways

Banca Akros
Research